|
|
||||||||
Comparative and Experimental Medicine, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996
Ocular infection with HSV results in a blinding immunoinflammatory lesion known as herpetic stromal keratitis (HSK). Early preclinical events include inflammatory cell, mainly neutrophils, infiltration of the stroma, and neovascularization. To further evaluate the role of neutrophils in pathogenesis, HSV infection was compared in BALB/c and mice of the same background, but lacking CXCR2, the receptor for chemokines involved in neutrophil recruitment. Our results show clear differences in the outcome of ocular HSV infection in CXCR2-/- compared with control BALB/c mice. Thus, CXCR2-/- animals had minimal PMN influx during the first 7 days postinfection, and this correlated with a longer duration of virus infection in the eye compared with BALB/c mice. The CXCR2-/- mice were also more susceptible to HSV-induced lesions and developed HSK upon exposure to a dose of HSV that was minimally pathogenic to BALB/c mice. The basis for the greater HSK lesion susceptibility of CXCR2-/- mice was associated with an elevated IL-6 response, which appeared in turn to induce the angiogenic factor, vascular endothelial growth factor. Our results serve to further demonstrate the critical role of angiogenesis in the pathogenesis of ocular lesions.
This article has been cited by other articles:
![]() |
S. J. Divito and R. L. Hendricks Activated Inflammatory Infiltrate in HSV-1-Infected Corneas without Herpes Stromal Keratitis Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1488 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Sarangi, B. Kim, E. Kurt-Jones, and B. T. Rouse Innate Recognition Network Driving Herpes Simplex Virus-Induced Corneal Immunopathology: Role of the Toll Pathway in Early Inflammatory Events in Stromal Keratitis J. Virol., October 15, 2007; 81(20): 11128 - 11138. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khan, N. Cole, E. B. Hume, L. Garthwaite, T. C. R. Conibear, D. H. Miles, Y. Aliwaga, M. B. Krockenberger, and M. D. P. Willcox The role of CXC chemokine receptor 2 in Pseudomonas aeruginosa corneal infection J. Leukoc. Biol., January 1, 2007; 81(1): 315 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kim, P. P. Sarangi, Y. Lee, S. Deshpande Kaistha, S. Lee, and B. T. Rouse Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation J. Leukoc. Biol., December 1, 2006; 80(6): 1405 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ebrahem, A. Minamoto, G. Hoppe, B. Anand-Apte, and J. E. Sears Triamcinolone Acetonide Inhibits IL-6- and VEGF-Induced Angiogenesis Downstream of the IL-6 and VEGF Receptors Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4935 - 4941. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Galioto, J. A. Hess, T. J. Nolan, G. A. Schad, J. J. Lee, and D. Abraham Role of Eosinophils and Neutrophils in Innate and Adaptive Protective Immunity to Larval Strongyloides stercoralis in Mice. Infect. Immun., October 1, 2006; 74(10): 5730 - 5738. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kim, S. Suvas, P. P. Sarangi, S. Lee, R. A. Reisfeld, and B. T. Rouse Vascular Endothelial Growth Factor Receptor 2-Based DNA Immunization Delays Development of Herpetic Stromal Keratitis by Antiangiogenic Effects J. Immunol., September 15, 2006; 177(6): 4122 - 4131. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. J. Carr, J. Ash, T. E. Lane, and W. A. Kuziel Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1. J. Gen. Virol., March 1, 2006; 87(Pt 3): 489 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. McClintock and E. M. Wagner Role of IL-6 in systemic angiogenesis of the lung J Appl Physiol, September 1, 2005; 99(3): 861 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Biswas, K. Banerjee, B. Kim, P. R. Kinchington, and B. T. Rouse Role of Inflammatory Cytokine-Induced Cycloxygenase 2 in the Ocular Immunopathologic Disease Herpetic Stromal Keratitis J. Virol., August 15, 2005; 79(16): 10589 - 10600. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kim, S. Lee, S. Suvas, and B. T. Rouse Application of Plasmid DNA Encoding IL-18 Diminishes Development of Herpetic Stromal Keratitis by Antiangiogenic Effects J. Immunol., July 1, 2005; 175(1): 509 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Banerjee, P. S. Biswas, and B. T. Rouse Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis J. Leukoc. Biol., January 1, 2005; 77(1): 24 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kim, Q. Tang, P. S. Biswas, J. Xu, R. M. Schiffelers, F. Y. Xie, A. M. Ansari, P. V. Scaria, M. C. Woodle, P. Lu, et al. Inhibition of Ocular Angiogenesis by siRNA Targeting Vascular Endothelial Growth Factor Pathway Genes: Therapeutic Strategy for Herpetic Stromal Keratitis Am. J. Pathol., December 1, 2004; 165(6): 2177 - 2185. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Biswas, K. Banerjee, M. Zheng, and B. T. Rouse Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein J. Leukoc. Biol., October 1, 2004; 76(4): 868 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Biswas, K. Banerjee, B. Kim, and B. T. Rouse Mice Transgenic for IL-1 Receptor Antagonist Protein Are Resistant to Herpetic Stromal Keratitis: Possible Role for IL-1 in Herpetic Stromal Keratitis Pathogenesis J. Immunol., March 15, 2004; 172(6): 3736 - 3744. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |